OOIR: Observatory of International Research

Papers

(The H4-Index of JACC: Cardiooncology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Full Issue PDF	155
Priorities in Cardio-Oncology	147
Balancing Promise and Evidence	117
Atrial Fibrillation in Patients With Cancer	98
Full Issue PDF	91
To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy	91
Full Issue PDF	88
Epigenomics of Cardio-Oncology	81
LAG3 Blockade Expands T Cells Within Atherosclerotic Plaque	75
Prospective Screening for Transthyretin Cardiac Amyloidosis in Spinal Stenosis Surgery Patients	70
Hormonal Therapy and Cardiovascular Health	69
Cancer Therapy and Exercise Intolerance: The Heart Is But a Part	68
Cardiovascular Safety in Oncology Clinical Trials	68
Behaviorally Designed Gamification and Physical Activity Among Breast and Prostate Cancer Survivors	62
Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy	61
SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes	60
Moving the Pendulum for Earlier Detection of Systolic and Diastolic Dysfunction in Cancer Survivors	53
Assessing Neurohormonal Antagonist Withdrawal in HER2+ Breast Cancer Patients With CTRCD	52
Full Issue PDF	52
Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy	48
Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients	47
Frailty	46
Cardiac Risk Stratification Before Lung Cancer Radiation	46
Proactive Surveillance for ICI Cardiotoxicity	45
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma	40

Incretin Mimetics in Cancer and Cardiovascular Disease	40
Long-Term, Implantable Event Monitoring of Patients With Wild-Type Transthyretin Cardiac Amyloidosis	39
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms	38
Risk Prediction in Cardio-Oncology: Conceptual and Methodological Considerations	37
Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)	37
Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy	37
Editorial Board/Officers Page	36
Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD	35
Atrial Fibrillation After Stem Cell Transplantation	34
Risk Stratification for Trastuzumab-Induced Cardiac Dysfunction and Potential Implications for Surveillance	34